Management of type 2 diabetes in the new era
In a combined multiple ascending dose and Phase IIa study in people with type 2 diabetes over 41 days, daily doses of cotadutide up to 200 g improved fasting and postprandial glucose levels and reduced body weight compared with placebo [79]
Research Education Hub Peptide Research Articles Explore educational research-use-only articles covering peptide structure, receptor signaling, model systems, scientific literature, documentation, and research limitations
[16] La ALCAR puede tener efectos neuroprotectores en el tratamiento de la enfermedad del Parkinson, pero se requieren estudios adicionales
10.1186/1479-5876-11-115 [DOI] [PMC free article] [PubMed] [Google Scholar] 71.Yano T, Liu Z, Donovan J, Thomas MK, Habener JF
It is vital for various metabolic processes, primarily acting as a carrier molecule